vs
Alexander & Baldwin, Inc.（ALEX）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Alexander & Baldwin, Inc.的1.4倍（$69.8M vs $51.0M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 7.4%，领先376.6%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -18.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -8.7%）
亚历山大-鲍德温公司是一家美国企业，曾是夏威夷领地时期五大财团之一，也是五大财团中最晚停止甘蔗种植的企业。目前公司主营房地产开发、土地运营以及建材与建筑业务，截至2020年，该公司是夏威夷最大的私人土地持有者之一，在当地拥有超2.8万英亩土地，运营着36处收益性物业。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ALEX vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.4倍
$51.0M
营收增速更快
RIGL
高出39.5%
-18.4%
净利率更高
RIGL
高出376.6%
7.4%
两年增速更快
RIGL
近两年复合增速
-8.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $51.0M | $69.8M |
| 净利润 | $3.8M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 17.1% | 33.2% |
| 净利率 | 7.4% | 384.0% |
| 营收同比 | -18.4% | 21.2% |
| 净利润同比 | -69.7% | 1769.2% |
| 每股收益（稀释后） | $0.05 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALEXRIGL
| Q4 25 | $51.0M | $69.8M | ||
| Q3 25 | $50.2M | $69.5M | ||
| Q2 25 | $51.7M | $101.7M | ||
| Q1 25 | $53.7M | $53.3M | ||
| Q4 24 | $62.4M | $57.6M | ||
| Q3 24 | $61.9M | $55.3M | ||
| Q2 24 | $51.0M | $36.8M | ||
| Q1 24 | $61.2M | $29.5M |
净利润ALEXRIGL
| Q4 25 | $3.8M | $268.1M | ||
| Q3 25 | $14.3M | $27.9M | ||
| Q2 25 | $25.1M | $59.6M | ||
| Q1 25 | $21.4M | $11.4M | ||
| Q4 24 | $12.4M | $14.3M | ||
| Q3 24 | $19.0M | $12.4M | ||
| Q2 24 | $9.1M | $-1.0M | ||
| Q1 24 | $20.0M | $-8.2M |
毛利率ALEXRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率ALEXRIGL
| Q4 25 | 17.1% | 33.2% | ||
| Q3 25 | 38.2% | 40.9% | ||
| Q2 25 | 54.4% | 60.1% | ||
| Q1 25 | 44.6% | 23.9% | ||
| Q4 24 | 28.3% | 28.9% | ||
| Q3 24 | 35.6% | 25.4% | ||
| Q2 24 | 31.8% | 1.2% | ||
| Q1 24 | 38.9% | -23.6% |
净利率ALEXRIGL
| Q4 25 | 7.4% | 384.0% | ||
| Q3 25 | 28.5% | 40.2% | ||
| Q2 25 | 48.6% | 58.6% | ||
| Q1 25 | 39.9% | 21.5% | ||
| Q4 24 | 19.9% | 24.9% | ||
| Q3 24 | 30.7% | 22.5% | ||
| Q2 24 | 17.8% | -2.8% | ||
| Q1 24 | 32.6% | -27.9% |
每股收益（稀释后）ALEXRIGL
| Q4 25 | $0.05 | $14.11 | ||
| Q3 25 | $0.20 | $1.46 | ||
| Q2 25 | $0.35 | $3.28 | ||
| Q1 25 | $0.29 | $0.63 | ||
| Q4 24 | $0.16 | $0.82 | ||
| Q3 24 | $0.26 | $0.70 | ||
| Q2 24 | $0.13 | $-0.06 | ||
| Q1 24 | $0.28 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.3M | $155.0M |
| 总债务越低越好 | $491.6M | $52.5M |
| 股东权益账面价值 | $987.2M | $391.5M |
| 总资产 | $1.7B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.50× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ALEXRIGL
| Q4 25 | $11.3M | $155.0M | ||
| Q3 25 | $17.3M | $137.1M | ||
| Q2 25 | $8.6M | $108.4M | ||
| Q1 25 | $16.9M | $77.1M | ||
| Q4 24 | $33.4M | $77.3M | ||
| Q3 24 | $17.9M | $61.1M | ||
| Q2 24 | $29.5M | $49.1M | ||
| Q1 24 | $15.7M | $49.5M |
总债务ALEXRIGL
| Q4 25 | $491.6M | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | $474.8M | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益ALEXRIGL
| Q4 25 | $987.2M | $391.5M | ||
| Q3 25 | $1.0B | $117.6M | ||
| Q2 25 | $1.0B | $81.9M | ||
| Q1 25 | $1.0B | $18.6M | ||
| Q4 24 | $1.0B | $3.3M | ||
| Q3 24 | $998.2M | $-14.6M | ||
| Q2 24 | $1.0B | $-29.9M | ||
| Q1 24 | $1.0B | $-31.7M |
总资产ALEXRIGL
| Q4 25 | $1.7B | $513.6M | ||
| Q3 25 | $1.7B | $242.5M | ||
| Q2 25 | $1.6B | $206.7M | ||
| Q1 25 | $1.6B | $176.0M | ||
| Q4 24 | $1.7B | $164.0M | ||
| Q3 24 | $1.7B | $139.4M | ||
| Q2 24 | $1.6B | $128.4M | ||
| Q1 24 | $1.6B | $126.5M |
负债/权益比ALEXRIGL
| Q4 25 | 0.50× | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | 0.47× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $79.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $27.3M | — |
| 自由现金流率自由现金流/营收 | 53.5% | — |
| 资本支出强度资本支出/营收 | 102.4% | — |
| 现金转化率经营现金流/净利润 | 21.06× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $57.2M | — |
8季度趋势，按日历期对齐
经营现金流ALEXRIGL
| Q4 25 | $79.5M | $22.0M | ||
| Q3 25 | $24.5M | $24.0M | ||
| Q2 25 | $16.5M | $30.5M | ||
| Q1 25 | $26.0M | $-893.0K | ||
| Q4 24 | $98.0M | $14.5M | ||
| Q3 24 | $35.3M | $21.7M | ||
| Q2 24 | $22.3M | $302.0K | ||
| Q1 24 | $16.1M | $-5.0M |
自由现金流ALEXRIGL
| Q4 25 | $27.3M | — | ||
| Q3 25 | $-3.7M | — | ||
| Q2 25 | $11.8M | — | ||
| Q1 25 | $21.8M | — | ||
| Q4 24 | $77.0M | — | ||
| Q3 24 | $31.4M | — | ||
| Q2 24 | $18.0M | — | ||
| Q1 24 | $12.3M | — |
自由现金流率ALEXRIGL
| Q4 25 | 53.5% | — | ||
| Q3 25 | -7.4% | — | ||
| Q2 25 | 22.8% | — | ||
| Q1 25 | 40.6% | — | ||
| Q4 24 | 123.4% | — | ||
| Q3 24 | 50.8% | — | ||
| Q2 24 | 35.3% | — | ||
| Q1 24 | 20.1% | — |
资本支出强度ALEXRIGL
| Q4 25 | 102.4% | — | ||
| Q3 25 | 56.1% | — | ||
| Q2 25 | 9.1% | — | ||
| Q1 25 | 7.8% | — | ||
| Q4 24 | 33.5% | — | ||
| Q3 24 | 6.2% | — | ||
| Q2 24 | 8.4% | — | ||
| Q1 24 | 6.1% | — |
现金转化率ALEXRIGL
| Q4 25 | 21.06× | 0.08× | ||
| Q3 25 | 1.71× | 0.86× | ||
| Q2 25 | 0.66× | 0.51× | ||
| Q1 25 | 1.21× | -0.08× | ||
| Q4 24 | 7.88× | 1.01× | ||
| Q3 24 | 1.86× | 1.75× | ||
| Q2 24 | 2.45× | — | ||
| Q1 24 | 0.80× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
